The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study

• Main Authors: Melissa Basile (Author), Jennifer Polo (Author), Katherine Henthorne (Author), Joan DeCelie-Germana (Author), Susan Galvin (Author), Janice Wang (Author)
• Format: Book
• Published: SAGE Publishing, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Elexacaftor/tezacaftor/ivacaftor (ETI) has reduced many symptoms of cystic fibrosis (CF). Objectives: We sought to identify the impact of ETI on both symptoms and treatment decisions among adults with CF. Design: Participants were enrolled in a cross-sectional study. Surveys were sent vi...